Back
Eaton Vance Enhanced Equity Income Fund Vs. Viking Therapeutics Industry Stock Comparison
Sell
50
EOI
Eaton Vance Enhanced Equity Income Fund
Last Price:
20.06
Seasonality Move:
1.76%
Sell
45
VKTX
Viking Therapeutics
Last Price:
63.15
Seasonality Move:
38.04%
Sell
50
Eaton Vance Enhanced Equity Income Fund (EOI)
is a Sell
Is Eaton Vance Enhanced Equity Income Fund a Buy, Sell or Hold?
- The current Eaton Vance Enhanced Equity Income Fund [EOI] share price is $20.01. The Score for EOI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- EOI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EOI Stock Price Chart
What is Eaton Vance Enhanced Equity Income Fund's stock price today?
-
The Eaton Vance Enhanced Equity Income Fund share price today is $20.01
The current trend is moderately bearish and EOI is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $63.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
EOI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 48.04 | Sell |
| Chaikin Money Flow: | -51713 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.95 - 20.33) | Sell |
| Bollinger Bands (100): | (18.94 - 20.04) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.92 | Buy |
| Relative Strength Index (14 RSI): | 44.37 | Sell |
| Chaikin Money Flow: | -27799915 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.04 - 71.46) | Sell |
| Bollinger Bands (100): | (52.9 - 66.58) | Buy |
EOI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.18 | Sell |
| 20-day SMA: | 20.21 | Sell |
| 50-day SMA: | 19.83 | Buy |
| 200-day SMA: | 18.78 | Buy |
| 8-day EMA: | 20.18 | Sell |
| 20-day EMA: | 20.14 | Sell |
| 50-day EMA: | 19.87 | Buy |
| 200-day EMA: | 18.78 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.43 | Sell |
| 20-day SMA: | 67.48 | Sell |
| 50-day SMA: | 64.43 | Sell |
| 200-day SMA: | 59.82 | Buy |
| 8-day EMA: | 69.69 | Sell |
| 20-day EMA: | 68.14 | Sell |
| 50-day EMA: | 65.07 | Sell |
| 200-day EMA: | 55.33 | Buy |
Eaton Vance Enhanced Equity Income Fund Earnings Growth & EOI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Eaton Vance Enhanced Equity Income Fund Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||